| HOME >> MEDICINE >> TECHNOLOGY |
968Long-term deferred tax liability
431
240Total liabilities
42,101
61,932Commitments and contingenciesStockholders' equity: Common stock – 15,310,426 and 13,765,857 shares issued and
outstanding at December 31, 2010 and March 31, 2010, respectively
153
138Class B stock – 1,162,500 shares issued and outstanding at December 31,
2010 and March 31, 2010, respectively
12
12 Additional paid-in capital
115,815
100,269Accumulated other comprehensive income
4,802
3,016Retained earnings
11,290
5,476Total stockholders' equity
132,072
108,911Total liabilities and stockholders' equity
$174,173
$170,843CHINDEX INTERNATIONAL, INC.SEGMENT INFORMATIONFor the nine months ended December 31, 2010 and the years ended March 31, 2010 and 2009, the Company operated in two businesses: Healthcare Services and Medical Products. The Company evaluates performance and allocates resources based on income or loss from operations before income taxes, not including foreign exchange gains or losses. The following segment information has been provided as per ASC 280 (in thousands):(in thousands except share data)Healthcare ServicesMedical ProductsTotalFor the three months ended December 31, 2010: Sales and service revenue
$26,115
$23,900
$50,015Gross Profit
n/a *
6,882
n/aGross Profit %
n/a *
29%
n/aIncome(loss) from operations before foreign exchange
$3,806
$(538)
$3,268Foreign exchange (loss)(446)Income from operations $2,822Other (expense), net(101)Income before income taxes$2,721As of December 31, 2010:Assets
$142,417
$31,756
$174,173Healthcare ServicesMedical ProductsTotalFor the three months ended December 31, 2009:Sales and service revenue
$21,563
$24,921
$46,484Gross Profit
<| SOURCE Chindex International, Inc. Copyright©2010 PR Newswire. All rights reserved |